Hematopoietic Stem Cell Transplant Clinical Trials

60 clinical trials for Hematopoietic Stem Cell Transplant across international registries, including 18 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Venetoclax Combined With Azacitidine for Consolidation Therapy in AML — RECRUITING · PHASE2
• PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV) — RECRUITING · PHASE2
• Study to Evaluate the Safety and Effectiveness of Withaferin A as a Treatment to Prevent GvHD in Transplant Patients — RECRUITING · PHASE1
• Coping Skills Training for Symptom Management and Daily Steps (Step Up) — RECRUITING · NA
• TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients — RECRUITING
• Ivosidenib as Post-HSCT Maintenance for AML — RECRUITING · PHASE2
• Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation — RECRUITING · NA
• Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors — RECRUITING · NA
• T Cell Therapy of Opportunistic Cytomegalovirus Infection — RECRUITING · PHASE1
• Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT) — RECRUITING · PHASE1
• Outcome of Allogeneic Hematopoietic Stem Cell Transplantation — RECRUITING
• PHASE 3 MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF VIRALYM-M (ALVR105) FOR THE TREATMENT OF PATIENTS WITH VIRUS-ASSOCIATED HEMORRHAGIC CYSTITIS AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT — RECRUITING · PHASE3
• PLATELET TRANSFUSIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION - THE PATH PHASE III TRIAL — RECRUITING · PHASE3
• NOVEL PULMONARY FUNCTION MEASURES FOR DIAGNOSIS OF BRONCHIOLITIS OBLITERANS SYNDROME (BOS) FOLLOWING HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN CHILDREN. — RECRUITING
• A RANDOMIZED PILOT TRIAL COMPARING ANTI-THYMOCYTE GLOBULIN (ATG) WITH ATG PLUS POST TRANSPLANT CYCLOPHOSPHAMIDE (PTCY) FOR PROPHYLAXIS AGAINST ACUTE AND CHRONIC GRAFT VERSUS HOST DISEASE (GVHD) IN MATCHED DONOR HEMATOPOIETIC CELL TRANSPLANTS (HCT) — RECRUITING
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF VEDOLIZUMAB IN THE PROPHYLAXIS OF INTESTINAL ACUTE GRAFT-VERSUS-HOST DISEASE IN SUBJECTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION — RECRUITING
• RANDOMIZED CONTROLLED TRIAL OF OLANZAPINE FOR THE CONTROL OF CHEMOTHERAPY-INDUCED VOMITING IN CHILDREN RECEIVING CHEMOTHERAPY FOR HEMATOPOIETIC STEM CELL TRANSPLANT CONDITIONING — RECRUITING
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, PHASE 3 STUDY OF THE SAFETY, TOLERABILITY, AND EFFICACY OF CMX001 FOR THE PREVENTION OF CYTOMEGALOVIRUS (CMV) INFECTION IN CMV-SEROPOSITIVE (R+) HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS — RECRUITING · PHASE3
• Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant — NOT_YET_RECRUITING
• Meaning-Centered Psychotherapy for Addressing Existential Distress of Patient/Caregiver Dyads Following Hematopoietic Stem Cell Transplantation: Feasibility and Acceptability — NOT_YET_RECRUITING · NA
• A Study Using Real-world Data to Examine Outcomes in Children and Adults Who Develop a Blood Clotting Disorder Called Thrombotic Microangiopathy (TMA) After Undergoing a Hematopoietic Stem Cell Transplant (HSCT). — COMPLETED
• Light Therapy to Treat Depression in Pediatric Stem Cell Therapy Recipients — WITHDRAWN · NA
• Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN — ACTIVE_NOT_RECRUITING · PHASE1
• Ruxolitinib for Early Lung Dysfunction After Hematopoietic Stem Cell Transplant — TERMINATED · PHASE2
• Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation — TERMINATED · PHASE4
• Safety and Efficacy of FT14 Conditioning for Allogeneic HSCT in Acute Myeloid Leukemia — ACTIVE_NOT_RECRUITING · PHASE2
• Oral Supplementation of 2'-Fucosyllactose in Allogeneic Bone Marrow Transplant Recipients — COMPLETED · PHASE1
• Pravastatin as a Prophylactic to Reduce Endothelial Injury in Pediatric Patients With Elevated Body Mass Index — COMPLETED · PHASE1
• A Study of the Effect of Laughter Therapy on the Mental Health and Quality of Survival of Hematopoietic Stem Cell Transplant Patients — NOT_YET_RECRUITING · NA
• Benefits of Intrahospital Exercise Program in Pediatric HSCT — COMPLETED · NA
• Long Term Arrhythmia Risk and Cardiovascular Events in Hematopoietic Stem Cell Transplant — COMPLETED
• IMPLEMENTING PHARMACOGENETICS IN THE BUSULFAN DOSING METHOD FOR CHILDREN UNDERGOING HEMATOPOIETIC STEM-CELL TRANSPLANTATION: A PROSPECTIVE, MULTICENTRIC, RANDOMIZED CLINICAL TRIAL. — NOT_YET_RECRUITING
• Reduced-Intensity Conditioning (RIC) and Myeloablative Conditioning (MAC) for HSCT in AML/MDS — COMPLETED · PHASE2
• Ultra-high Dose Vitamin D for HSCT — COMPLETED · PHASE1
• Patient Reported Outcomes and Patient Education in Cellular Therapy Patients — COMPLETED · NA
• Impact of Prehabilitation in Oncology Via Exercise- Bone Marrow Transplant — COMPLETED · NA
• A Randomized Trial of Vitamin D Supplementation With or Without Vitamin A in Stem Cell Transplantation — COMPLETED · NA
• Time Restricted Nutrition in Pediatric Stem Cell Transplant Recipients — COMPLETED · NA
• PHASE 2/3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND EFFICACY OF ALVR105 (VIRALYM-M) COMPARED TO PLACEBO FOR THE PREVENTION OF ADV, BKV, CMV, EBV, HHV-6, AND JCV INFECTION AND/OR DISEASE, IN HIGH-RISK PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT — COMPLETED · PHASE2
• Developing Self-Management Interventions After HCT — COMPLETED
• Efficacy of N-acetylcysteine Versus Placebo as Prophylaxis of Sinusoidal Obstruction Syndrome in Patients Undergoing Hematopoietic Stem Cell Transplantation — OTHER · PHASE2
• Prospective Study on the Vaccine Response to Meningococcal B Vaccine After Allogeneic Stem Cell Transplantation — COMPLETED · NA
• Effects of Compassion Training to Patients Undergoing HSCT on Biological and Psychosocial Parameters — COMPLETED · NA
• A PHASE III, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, MULTI-CENTRE STUDY EVALUATING THE SAFETY, TOLERABILITY AND EFFICACY OF COMBINATION TREATMENT OF BL-8040 AND G-CSF AS COMPARED TO PLACEBO AND G-CSF FOR THE MOBILIZATION OF HEMATOPOIETIC STEM CELLS FOR AUTOLOGOUS TRANSPLANTATION IN SUBJECTS WITH MULTIPLE MYELOMA ¿ THE GENESIS STUDY — NOT_YET_RECRUITING · PHASE3
• RANDOMIZED CLINICAL STUDY OF HAPLO-IDENTICAL DONORS VERSUS UNRELATED DONORS — COMPLETED
• Music Therapy and Hematopoietic Stem Cell Transplant — COMPLETED · NA
• THE EFFECTIVENESS OF LACTOBACILLUS PLANTARUM (LBP, IND#17339) IN PREVENTING ACUTE GRAFT-VERSUS-HOST DISEASE (GVHD) IN CHILDREN UNDERGOING ALTERNATIVE HEMATOPOIETIC PROGENITOR CELL TRANSPLANTATION (HCT) — COMPLETED
• Haploidentical and Mismatched Unrelated Donors Hematopoietic Stem Cell Transplant — OTHER · PHASE2
• T-cell Depleted Hematopoietic Stem Cell Boosts Without Conditioning for Poor Marrow Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation — TERMINATED · PHASE2
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, ACTIVE COMPARATOR-CONTROLLED, MULTICENTER CLINICAL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF V114 IN RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (PNEU-STEM) — COMPLETED · PHASE3

Refine this search